BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2065719)

  • 1. Binding affinities of hexahydro-difenidol and hexahydro-sila-difenidol analogues at four muscarinic receptor subtypes: constitutional and stereochemical aspects.
    Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Lambrecht G; Christophe J
    Eur J Pharmacol; 1991 Feb; 206(2):95-103. PubMed ID: 2065719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
    Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E
    Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselectivity of (R)- and (S)-hexahydro-difenidol binding to neuroblastoma M1, cardiac M2, pancreatic M3, and striatum M4 muscarinic receptors.
    Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Lambrecht G; Christophe J
    Chirality; 1991; 3(2):118-23. PubMed ID: 1863523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J; Strohmann C; Linoh H; Zilch H; Tacke R; Mutschler E; Lambrecht G
    Br J Pharmacol; 1989 Sep; 98(1):197-205. PubMed ID: 2804545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of hexahydro-difenidol, hexahydro-sila-difenidol and related selective muscarinic antagonists.
    Lambrecht G; Feifel R; Moser U; Wagner-Röder M; Choo LK; Camus J; Tastenoy M; Waelbroeck M; Strohmann C; Tacke R
    Trends Pharmacol Sci; 1989 Dec; Suppl():60-4. PubMed ID: 2694525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.
    Waelbroeck M; Camus J; Tastenoy M; Feifel R; Mutschler E; Tacke R; Strohmann C; Rafeiner K; Rodrigues de Miranda JF; Lambrecht G
    Br J Pharmacol; 1994 Jun; 112(2):505-14. PubMed ID: 8075869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
    Waelbroeck M; Camus J; Tastenoy M; Christophe J
    Br J Pharmacol; 1992 Jan; 105(1):97-102. PubMed ID: 1596694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p-Fluoro-hexahydro-sila-difenidol exhibits poor selectivity between M3 and M1 muscarinic receptors.
    Meng Y; Hu J; el-Fakahany EE
    Membr Biochem; 1990; 9(4):293-300. PubMed ID: 1967074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
    Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
    Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective interaction of procyclidine, hexahydro-difenidol, hexbutinol and oxyphencyclimine, and of related antagonists, with four muscarinic receptors.
    Waelbroeck M; Camus J; Tastenoy M; Mutschler E; Strohmann C; Tacke R; Schjelderup L; Aasen A; Lambrecht G; Christophe J
    Eur J Pharmacol; 1992 Sep; 227(1):33-42. PubMed ID: 1426023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of muscarinic M2 and M3, but not of M1 and M4 receptors in vagally stimulated contractions of rabbit bronchus/trachea.
    Eltze M; Galvan M
    Pulm Pharmacol; 1994 Apr; 7(2):109-20. PubMed ID: 8081071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type.
    Waelbroeck M; Camus J; Tastenoy M; Lambrecht G; Mutschler E; Kropfgans M; Sperlich J; Wiesenberger F; Tacke R; Christophe J
    Br J Pharmacol; 1993 Jun; 109(2):360-70. PubMed ID: 8102927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselectivity of procyclidine binding to muscarinic receptor subtypes M1, M2 and M4.
    Waelbroeck M; Camus J; Tastenoy M; Lambrecht G; Mutschler E; Tacke R; Christophe J
    Eur J Pharmacol; 1990 Sep; 189(2-3):135-42. PubMed ID: 2253700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereoselective inhibition of muscarinic receptor subtypes by the enantiomers of hexahydro-difenidol and acetylenic analogues.
    Feifel R; Wagner-Röder M; Strohmann C; Tacke R; Waelbroeck M; Christophe J; Mutschler E; Lambrecht G
    Br J Pharmacol; 1990 Mar; 99(3):455-60. PubMed ID: 2331578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective labelling of muscarinic M1 receptors in calf superior cervical ganglia by [3H](+/-)-telenzepine.
    Feifel R; Rodrigues de Miranda JF; Strohmann C; Tacke R; Aasen AJ; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1991 Mar; 195(1):115-23. PubMed ID: 2065706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic cholinergic receptors in the rat caudate-putamen and olfactory tubercle belong predominantly to the m4 class: in situ hybridization and receptor autoradiography evidence.
    Vilaró MT; Wiederhold KH; Palacios JM; Mengod G
    Neuroscience; 1991; 40(1):159-67. PubMed ID: 2052149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclic AMP formation in N1E-115 neuroblastoma cells is mediated by a non-cardiac M2 muscarinic receptor subtype.
    Surichamorn W; Amrhein CL; Forray C; el-Fakahany EE
    Brain Res; 1989 Jul; 493(2):320-5. PubMed ID: 2548669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic M1 and M3 receptors in rat striatum: a binding study.
    de la Vega MT; Nuñez A; Arias-Montaño JA
    Arch Med Res; 1997; 28(4):493-7. PubMed ID: 9428572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1991 Sep; 40(3):413-20. PubMed ID: 1896027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p-Fluoro-hexahydro-sila-difenidol: affinity for vascular muscarinic receptors.
    Duckles SP
    Eur J Pharmacol; 1990 Aug; 185(2-3):227-30. PubMed ID: 2253696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.